In vitro metabolism of a triclyclic alkaloid (M445526) in human liver microsomes and hepatocytes

The in vitro metabolism of M445526 (ZD6126 phenol) was investigated by incubating [14C]-M445526 at a concentration of 10 µg ml−1 with human hepatic microsomes (4 mg ml−1) or human hepatocytes (2 × 106 cells ml−1) for up to 180 min. Following incubation with microsomes and hepatocytes, up to 78% and...

Full description

Saved in:
Bibliographic Details
Published inXenobiotica Vol. 37; no. 9; pp. 972 - 985
Main Authors McCormick, A. D., Slamon, D. L., Lenz, E. M., Phillips, P. J., King, C. D., Mckillop, D., Roberts, D. W.
Format Journal Article
LanguageEnglish
Published England Informa UK Ltd 01.09.2007
Taylor & Francis
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The in vitro metabolism of M445526 (ZD6126 phenol) was investigated by incubating [14C]-M445526 at a concentration of 10 µg ml−1 with human hepatic microsomes (4 mg ml−1) or human hepatocytes (2 × 106 cells ml−1) for up to 180 min. Following incubation with microsomes and hepatocytes, up to 78% and 40% of [14C]-M445526 was metabolized after 180 and 120 min, respectively. High-performance liquid chromatography (HPLC) with radiochemical detection confirmed extensive metabolism of [14C]-M445526 by microsomes and hepatocytes. Mass spectrometry and 1H-NMR spectroscopy enabled structural identification of up to eight metabolites. Human liver microsomes formed one major (O-desmethyl) and three minor (a further O-desmethyl and two different hydroxylated) phase I metabolites. Human hepatocytes produced one major metabolite, a sulphate conjugate of the major O-desmethyl metabolite formed by microsomes. Four minor metabolites were also formed, primarily by O-demethylation with subsequent glucuronidation. Taken collectively, [14C]-M445526 underwent extensive in vitro metabolism by human liver fractions. These data were confirmed by subsequent human in vivo studies.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0049-8254
1366-5928
DOI:10.1080/00498250701620718